Sean A. McCarthy - 19 May 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Issuer symbol
CTMX
Transactions as of
19 May 2023
Net transactions value
+$26,041
Form type
4
Filing time
23 May 2023, 16:52:51 UTC
Previous filing
20 Mar 2023
Next filing
22 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Options Exercise $26,041 +16,535 +4.3% $1.57 405,356 19 May 2023 Direct F1
holding CTMX Common Stock 93,158 19 May 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Options Exercise $0 -16,535 -12% $0.000000 119,536 19 May 2023 Common Stock 16,535 $1.57 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 161,250 restricted stock units.
F2 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
F3 This option is fully vested and exercisable.